Abstract
The paper presents the results of a survey of 254 patients of reproductive and menopausal age who after the completion of the surgical, in some patients also chemo-radiotherapY., received tamoxifen for breast cancer for different lengths of time. All patients underwent ultrasound examination of pelvic organs and determination of the content of estradiol, follicle-stimulating and luteinizing hormones in the serum. It was showed that with tamoxifen therapy ovarian cysts were diagnosed in 50 women with preserved menstrual cycle (73.5%) and 31 - in menopause (16.6%). Detection of cysts in 72% of patients of reproductive age and 19.3% of menopausal age was accompanied by increased production of estradiol. Cyst formation and hyperproduction of estradiol appeared mainly during the first year of tamoxifen; in the future they could disappear, which made it possible to observe such patients and not immediately made a decision about the need for pharmacological or surgical suppression of ovarian function.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
